Wire Stories
Atom Bioscience to Present Final Data from its Positive Phase 2a Clinical Trial in Chronic Gout at American College of Rheumatology Annual Meeting, Nov. 10 � 14, in Philadelphia, PA
�ABP-671 effective at lowering serum uric acid,�the cause of gout JIANGSU, China–(BUSINESS WIRE)–Atom Bioscience, a clinical stage biotechnology company developing new treatments...